Kingsview Wealth Management LLC Sells 4,466 Shares of UnitedHealth Group Incorporated $UNH

Kingsview Wealth Management LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the fourth quarter, Holdings Channel reports. The fund owned 35,145 shares of the healthcare conglomerate’s stock after selling 4,466 shares during the period. Kingsview Wealth Management LLC’s holdings in UnitedHealth Group were worth $11,602,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Beacon Financial Strategies CORP bought a new position in UnitedHealth Group during the 4th quarter worth $26,000. Anfield Capital Management LLC increased its position in UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management bought a new position in UnitedHealth Group during the 4th quarter worth $27,000. Foster Dykema Cabot & Partners LLC increased its position in UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares during the period. Finally, 1248 Management LLC bought a new position in UnitedHealth Group during the 3rd quarter worth $29,000. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.28% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on UNH shares. Mizuho increased their price objective on UnitedHealth Group from $410.00 to $440.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 20th. Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target on the stock in a research report on Wednesday, April 1st. Jefferies Financial Group raised their price target on UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research report on Tuesday, April 7th. Finally, Leerink Partners raised their price target on UnitedHealth Group from $345.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $397.63.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $384.38 on Thursday. The stock’s 50-day simple moving average is $333.04 and its 200 day simple moving average is $320.73. The firm has a market capitalization of $349.07 billion, a PE ratio of 29.03, a price-to-earnings-growth ratio of 1.62 and a beta of 0.64. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $404.15.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The business had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. During the same period last year, the firm posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.